European journal of clinical investigation
-
Eur. J. Clin. Invest. · Jun 2021
Meta AnalysisBMI and Atrial Fibrillation Recurrence Post Catheter Ablation: A Dose-Response Meta-analysis.
The evidence on the association between obesity and atrial fibrillation (AF) recurrence was equivocal. We aimed to evaluate the dose-response relationship between body mass index (BMI) and AF recurrence and adverse events. ⋯ CRD42020198787.
-
Eur. J. Clin. Invest. · May 2021
Review Meta AnalysisThe association between serum homocysteine and depression: a systematic review and meta-analysis of observational studies.
Hyperhomocysteinaemia is known to interfere with neurological functions; however, there is a controversy regarding the relationship between homocysteine and depression. ⋯ Homocysteinemia level is higher in individuals with depression. However, the depression diagnostic tool used is instrumental in influencing their association, and thus, future studies should focus on the tools for depression assessment.
-
Eur. J. Clin. Invest. · May 2021
Review Meta AnalysisTooth Brushing Frequency and Gastric and Upper Aerodigestive Tract Cancers Risk: A Meta-analysis.
Results of epidemiological studies evaluating the association between toothbrushing and gastric and upper aerodigestive tract (UADT) cancer risk showed inconsistent results. The purpose of this study was to evaluate the association between toothbrushing and gastric and UADT cancer risk and quantify the dose-response association between them. ⋯ This meta-analysis suggested the negative relationship between frequency of toothbrushing and risk of gastric and UADT cancers. Toothbrushing may be a protective factor for gastric and UADT cancers. However, this association must be further validated through large prospective studies.
-
Eur. J. Clin. Invest. · Apr 2021
Review Meta AnalysisEffect of low-dose colchicine in acute and chronic coronary syndromes.
Sparse evidence of the prognostic benefit of the anti-inflammatory drug colchicine in chronic and acute coronary syndromes (CCS/ACS) exists. ⋯ Colchicine therapy near halves the risk of cardiovascular events in CCS compared with placebo and is associated with a nonsignificant 23% risk reduction in ACS, together with a trend towards a greater reduction of hs-CRP.